Cadayson, Baby Boy .

HRN: 22-55-55  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/31/2023
02/06/2023
IV
34
Q24
Psnb
Waiting Final Action 
01/31/2023
AMPICILLIN 250MG (VIAL)
01/31/2023
02/06/2023
IV
115
Q12
Psnb
Waiting Final Action 
02/04/2023
CEFTAZIDIME 1GM (VIAL)
02/04/2023
02/11/2023
IV
60mg
Q8hrs
Neonatal Sepsis
Waiting Final Action 
11/14/2024
CEFUROXIME 1.5GM (VIAL)
11/14/2024
11/21/2024
IV
1 Gram
Q8h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: